Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Details for Australian Patent Application No. 2007253998 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Bender, John A.; Hewawasam, Piyasena; Ding, Min; Gentles, Robert G.

Agent A J Park

Pub. Number AU-B-2007253998

PCT Pub. Number WO2007/136982

Priority 60/894,757 14.03.07 US; 60/802,005 19.05.06 US; 60/852,084 16.10.06 US; 60/801,125 17.05.06 US

Filing date 4 May 2007

Wipo publication date 29 November 2007

Acceptance publication date 15 March 2012

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/136982 Priority application(s): WO2007/136982

15 March 2012 Application Accepted

  Published as AU-B-2007253998

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007254004-Engineered antibody-stress protein fusions

2007253997-Steerable catheter using flat pull wires and method of making same